BioChem Pharma to offer 3,000,000 common shares.LAVAL, Canada--(BUSINESS WIRE)--Feb. 6, 1996--BioChem Pharma Inc. (BioChem Pharma) announced today that it is filing a preliminary prospectus Preliminary Prospectus A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders in Canada and a registration statement in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. under the Canada/U.S. multijurisdictional disclosure system for an offering of 3,000,000 Common Shares. In addition, BioChem Pharma will grant to the underwriters an option to purchase an additional 450,000 Common Shares to cover over-allotments. BioChem Pharma intends to use the net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). of this offering to fund possible future acquisitions of companies, technology, product rights and distribution rights, although no such acquisitions are being negotiated as of the date hereof. The Company may also use a portion of the net proceeds of the offering to fund its research and development programs, including preclinical testing and clinical trials for products under development and to enhance the commercialization of some of the Company's products. The underwriters of the offering are Hambrecht & Quist LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Securities Inc., Robertson, Stephens & Company LLC, Midland Walwyn Capital Inc. and Levesque Beaubien Geoffrion Inc. The prospectus is being filed simultaneously with securities regulatory authorities in all provinces of Canada and with the U.S. Securities and Exchange Commission under the Canada/U.S. multijurisdictional disclosure system. The definitive terms of the offering will be determined at the end of the marketing process on or about the end of February 1996. A registration statement relating to the Common Shares has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. The Common Shares may not be sold nor may offers to buy the Common Shares be accepted prior to the time the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Common Shares in any State in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State. BioChem Pharma is an international biopharmaceutical company dedicated to the research, development and commercialization of innovative products for the prevention, detection and treatment of human diseases. The Company's Common Shares are traded on the Montreal and Toronto Stock exchanges Toronto Stock Exchange (TSE) Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options. (BCH BCH Beach BCH Banco Central de Honduras BCH Boot Console Handler BCH Boulder Community Hospital (Boulder, CO, USA) BCH Broadcast Channel BCH Belfast City Hospital BCH Banco Central-Hispano ) and on the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on National Market (BCHXF). CONTACT: Christine Lennon Fran ois Legault Vice President, Investor Senior Vice President, Relations and Corporate Finance, Administration and Communications -OR- Treasurer BioChem Pharma Inc. BioChem Pharma Inc. (514) 978-7771 (514) 978-7891 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion